Table 1 Minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) of antimicrobial peptides against Acinetobacter baumannii 17,978, 19,606 and multiple drug-resistant (MDR) clinical strains.

From: Identification of potential therapeutic antimicrobial peptides against Acinetobacter baumannii in a mouse model of pneumonia

Peptide

17,978

19,606

MDRAB clinical strains#

MIC (μg/ml)

MBC (μg/ml)

MIC (μg/ml)

MBC (μg/ml)

MIC (μg/ml)

MBC (μg/ml)

A2

32

32

8

8

8–32

8–64

BMAP-27

16

16

8

8

4–16

8–32

CAME

32

32

32

32

8–32

8–64

SMAP-29

8

8

8

8

4–32

4–64

H1a

32

32

16

16

8–16

8–32

Latarcin 2a

16

16

16

16

8–64

8–64

MaximinH2

64

128

32

32

16–128

16–128

NRC12

16

16

16

16

8–32

8–32

Pilosulin

16

32

16

16

8–16

8–32

Pleurocidin

16

16

16

16

8–32

8–32

Q6

16

16

16

16

8–16

8–32

TP4

16

16

16

16

8–32

8–32

  1. #Details are available in Supplementary Table 2.